Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Marine microbes could be used in cosmetics for sun protection, skin care, and possibly preventing hair loss.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Cow placenta extract has strong antioxidant effects and can delay skin aging in mice.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

The stiffness of a wound affects hair growth during healing, with less stiff areas growing more hair.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

New medications could improve treatment for severe alopecia areata in Australia.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Certain genes are more active during wound healing in axolotl and Acomys, which could help develop materials that improve human wound healing and regeneration.

Understanding molecular mediators can improve skin healing treatments.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.